In 2016, concerns regarding retinopathy associated with GLP-1 were first raised in the Semaglutide Unabated Sustainability in Treatment of T2DM (SUSTAIN) 6 trial with semaglutide [89]
La mayora de los estudios utilizan dosis de 1-10 mil millones de CFU diarios durante al menos 8-12 semanas para evaluar efectos
While they are found throughout the body, they are most prominent in the skin, the upper and lower respiratory tract, and the gastrointestinal tract (Tharp, 1990)
Watch for unusual heat or swelling
Early data suggests aleniglipron could be one of the most promising oral GLP-1 candidates so far
Altogether, your semaglutide provider evaluates your medical history, current medication, lifestyle, and personal targets to develop a plan aligning with your needs